Related Experiment Videos
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
1-trifluoromethoxyphenyl-3-(1-propionylpiperidin-4-yl) urea (TPPU), a soluble epoxide hydrolase inhibitor, lowers L-NAME-induced hypertension through suppression of angiotensin-converting enzyme in rats.
European review for medical and pharmacological sciences·2020
Practical guide to the Idea, Development and Exploration stages of the IDEAL Framework and Recommendations.
The British journal of surgery·2016
Vascular hepoxilin and trioxilins mediate vasorelaxation through TP receptor inhibition in mouse arteries.
Acta physiologica (Oxford, England)·2015
Survey of management of common iliac artery aneurysms by members of the Vascular Society of Great Britain and Ireland.
Annals of the Royal College of Surgeons of England·2014
Prophylaxis of venous thromboembolism in general surgery: guidelines differ and we still need local policies.
Annals of the Royal College of Surgeons of England·2011
A prospective randomised controlled trial and economic modelling of antimicrobial silver dressings versus non-adherent control dressings for venous leg ulcers: the VULCAN trial.
Health technology assessment (Winchester, England)·2009
Prevention in managed care: obstacles and opportunities.
Journal of the Tennessee Medical Association·1996
Pulmonary abscess due to Corynebacterium striatum.
Journal of the Tennessee Medical Association·1996
Ten-year summary of human immunodeficiency virus serology in west Tennessee.
Journal of the Tennessee Medical Association·1996
Associations of Cholesin and GPR146 with atherosclerotic plaque stability: integrated bioinformatics and functional analyses.
Frontiers in cardiovascular medicine·2026
Caveolin-1 levels associated with coronary artery disease in Chinese participants: a retrospective cohort study.
Frontiers in cardiovascular medicine·2026
PCSK9 inhibitors for lipid-lowering treatment in patients with atherosclerotic cardiovascular disease: a health technology assessment.
Frontiers in cardiovascular medicine·2026